Robertet SA Cert.d'Invest. Em.87 (CBE) AI Stock Analysis

• Market Cap: €1.55B
• Dividend Yield: 2.66%
• Average Volume (3M): 18.00
• Price to Earnings (P/E): 16.1
• Beta (1Y): 0.06
• Revenue Growth: 11.99%
• EPS Growth: 20.45%
• Country: FR
• Employees: 2,587
• Sector: Basic Materials
• Sector Strength: 67
• Industry: Chemicals
• EPS (TTM): 18.33
• Shares Outstanding: 137,799
• 10 Day Avg. Volume: 18
• 30 Day Avg. Volume: 18
• PEG Ratio: 0.61
• Price to Book (P/B): 3.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 21.15
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €849.00
• Price Target Upside: 22.16% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 73 Outperform
• Price Target: €785.00 ▲(12.95%Upside)

Robertet SA's strong financial performance is the primary driver of its score, supported by robust revenue growth and efficient cost management. However, technical analysis indicates potential bearish trends, and the valuation suggests the stock is fairly priced. The absence of recent earnings call insights or notable corporate events leads to a score that reflects existing fundamentals without speculative influences.

Robertet SA Cert.d'Invest. Em.87 Business Overview & Revenue Model

Company Description

Robertet SA is a French company that specializes in the production and distribution of natural aromatic products. It operates in the fragrance, flavor, and health & beauty sectors, offering a range of natural ingredients and compounds. The company is renowned for its expertise in sourcing, transforming, and utilizing natural raw materials to create high-quality end products for various industries, including food and beverage, cosmetics, and personal care.

How the Company Makes Money

Robertet SA generates revenue primarily through the sale of its natural aromatic products and ingredients. The company's key revenue streams include the production and distribution of fragrances, flavors, and health & beauty products. By leveraging its extensive expertise in natural raw materials, Robertet caters to a diverse clientele across multiple industries, including food and beverage manufacturers, cosmetic companies, and personal care brands. The company also benefits from strategic partnerships and collaborations with other industry players, which enhance its product offerings and market reach. Additionally, Robertet's commitment to innovation and sustainability in sourcing and production processes contributes to its competitive advantage and financial performance.

Robertet SA Cert.d'Invest. Em.87 Financial Statement Overview

Summary

Robertet SA exhibits strong financial health with robust revenue growth, efficient cost management, and solid cash flow generation. The balance sheet is well-capitalized, though the increase in debt levels warrants careful monitoring. With continued focus on improving net margins and managing leverage, the company is well-positioned for sustainable growth.

Income Statement

Robertet SA has demonstrated a healthy growth in total revenue, with a significant increase from €721 million in 2023 to €808 million in 2024, marking a revenue growth rate of approximately 12%. The gross profit margin is strong, reflecting efficient production and cost management. EBIT and EBITDA margins are solid, indicating robust operational efficiency. However, the net profit margin could be improved, suggesting potential areas for cost optimization.

Balance Sheet

The company maintains a healthy equity ratio, highlighting strong capitalization with stockholders' equity making up 55% of total assets. The debt-to-equity ratio is moderate, indicating manageable leverage levels. However, there has been an increase in total debt from 2023 to 2024, which could pose risks if not carefully managed. Return on equity remains satisfactory, reflecting effective utilization of shareholder funds.

Cash Flow

Operating cash flow has increased from €102 million in 2023 to €112 million in 2024, demonstrating strong cash-generating capability. The free cash flow is positive and stable, though there was a slight decline from the previous year. This suggests effective capital expenditure management, although further improvements could enhance cash flow consistency.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	807.61M	721.13M	703.04M	606.09M	538.32M
Gross Profit	455.19M	391.79M	108.44M	101.89M	82.08M
EBITDA	160.03M	132.89M	125.61M	110.99M	92.14M
Net Income	90.07M	74.60M	76.02M	71.71M	50.58M
Balance Sheet
Total Assets	1.01B	927.13M	847.21M	783.29M	669.71M
Cash, Cash Equivalents and Short-Term Investments	193.47M	172.59M	128.06M	190.01M	150.85M
Total Debt	268.00M	325.63M	297.87M	112.73M	87.27M
Total Liabilities	456.07M	460.72M	431.43M	237.39M	193.41M
Stockholders Equity	551.80M	465.51M	414.99M	545.73M	476.26M
Cash Flow
Free Cash Flow	73.82M	84.47M	24.11M	64.34M	86.24M
Operating Cash Flow	112.41M	101.82M	46.87M	85.12M	101.07M
Investing Cash Flow	-38.33M	-81.21M	-67.36M	-45.83M	-22.97M
Financing Cash Flow	-58.93M	-2.30M	-43.28M	-4.69M	-22.03M

Robertet SA Cert.d'Invest. Em.87 Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 695.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:CBE, the sentiment is Negative. The current price of 695 is below the 20-day moving average (MA) of 709.29, below the 50-day MA of 733.97, and below the 200-day MA of 743.33, indicating a bearish trend. The MACD of -11.35 indicates Positive momentum. The RSI at 40.46 is Neutral, neither overbought nor oversold. The STOCH value of 8.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:CBE.

Robertet SA Cert.d'Invest. Em.87 Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CBE	73 Outperform	€1.55B	16.14		2.66%	11.99%	20.45%
RBT	73 Outperform	€1.55B	18.42	17.71%	2.33%	11.99%	20.45%
ALBKK	73 Outperform	€75.60M	19.95	8.65%	1.44%	32.61%	303.52%
AKE	66 Neutral	€4.76B	15.06	4.87%	5.72%	2.71%	-10.61%
Sector *	58 Neutral	€1.18B	6.02	-1.74%	5.45%	26.19%	-52.76%
NK	47 Neutral	€2.21B	50.11	-2.97%	10.76%	-4.99%	-286.16%